ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Questionnaires"

  • Abstract Number: 2272 • 2019 ACR/ARP Annual Meeting

    Self-reported Anxiety, Depression and Levels of Physical Activity in Patients with Adult Idiopathic Inflammatory Myopathies

    Kristofer Andreasson1, Helene Alexanderson 1 and Heléne Sandlund 2, 1Karolinska Institutet, Stockholm, Sweden, 2Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: The adult idiopathic inflammatory myopathies (IIM) comprise dermatomyositis (DM), necrotizing myopathy (NM), antisynthetase syndrome (ASS), overlap myositis and inclusion body myositis (IBM). Impaired muscle…
  • Abstract Number: 697 • 2019 ACR/ARP Annual Meeting

    Differing Opinions on Clinical Research Between Healthcare Providers and Lupus Patients

    Cristina Arriens1, Dylan Forciea 2, Judith James 1 and Joan T. Merrill 3, 1Oklahoma Medical Research Foundation, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Oseberg, Oklahoma City, OK, 3Okalahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Although SLE disproportionately affects minority racial groups, this population is significantly under-represented in clinical trials, increasing risk for underpowered, incorrect conclusions in race-based sub-group…
  • Abstract Number: 728 • 2017 ACR/ARHP Annual Meeting

    Symptoms of Autonomic Dysfunction in Systemic Sclerosis Assessed By the Compass-31 Questionnaire

    Brittany Adler1, James Russell2, Laura K. Hummers3 and Zsuzsanna McMahan4, 1Rheumatology, Johns Hopkins University, Baltimore, MD, 2Neurology, Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD, 3Medical and Rheumatology, Johns Hopkins University, Baltimore, MD, 4Department of Internal Medicine, Johns Hopkins University, Baltimore, MD

    Background/Purpose: Autonomic dysfunction is a known complication of systemic sclerosis (SSc) and can affect vascular tone, gastrointestinal (GI) motility, and heart rate and blood pressure…
  • Abstract Number: 2466 • 2016 ACR/ARHP Annual Meeting

    Remission According to RAPID3 (routine assessment of patient index data 3) in Patients with Rheumatoid Arthritis: A Cross-Sectional 3 Center Study from Routine Care

    Isabel Castrejón1, Martin J. Bergman2, Kathryn Gibson3,4, Yusuf Yazici5, Joel Block6 and Theodore Pincus1, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Taylor Hospital, Ridley Park, PA, 3Liverpool Hospital, Sydney, Sydney, Australia, 4Ingham Research Institute, Liverpool, Australia, 5Division of Rheumatology, NYU Hospital for Joint Diseases, New York, NY, 6Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: Remission rates in patients with rheumatoid arthritis (RA) according to RAPID3 (routine assessment of patient index data) are reported at 25% in France1 and…
  • Abstract Number: 2519 • 2016 ACR/ARHP Annual Meeting

    Predictors of Flare in Rheumatoid Arthritis Patients Treated Preventively with Rituximab: A Prospective Study Using Ultrasound and Patient Reported Outcomes

    Mediola Ismajli1 and Maria J. Leandro2, 1Rheumatology, University College London Hospital, London, United Kingdom, 2Centre for Rheumatology, Division of Medicine, University College London, London, United Kingdom

    Title: Predictors of flare in rheumatoid arthritis patients treated preventively with rituximab: a prospective study using ultrasound and patient reported outcomes Background/Purpose: Rituximab (RTX) is…
  • Abstract Number: 2895 • 2016 ACR/ARHP Annual Meeting

    Adaptation of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract 2.0 Questionnaire into Turkish

    Murat Yasar Tas1, Gozde Dervis Hakim2, Pembe Keskinoglu3, Gokce Kenar4, Handan Yarkan5, Berrin Zengin4, Gerçek Can5, Fatos Onen4, Nurullah Akkoc4, Mesut Akarsu6 and Merih Birlik4, 1Internal Medicine, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 2Gastroenterology, Ataturk State Hospital, Sinop, Turkey, 3Department of Biostatistics and Medical Informatics, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 4Rheumatology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey, 5Rheumatology, Dokuz Eylul University Faculty of Medicine, İzmir, Turkey, 6Gastroenterology, Dokuz Eylul University Faculty of Medicine, Izmir, Turkey

    Background/Purpose:  Nearly 90% of patients with scleroderma (SSc) have gastrointestinal tract(GIT) involvement in variable severities and is a challenging process for clinicians.The University of California…
  • Abstract Number: 2713 • 2014 ACR/ARHP Annual Meeting

    The Relationship of Patient Reported Skin Symptoms to the Scleroderma HAQ, the Modified Rodnan Skin Score and Skin Pathology. 

    Jessica Ziemek1, Ada Man2, Robert W. Simms2 and Robert Lafyatis2, 1Rheumatology/Arthritis Center, Boston University School of Medicine, Boston, MA, 2Rheumatology, Boston University School of Medicine, Boston, MA

    Background/Purpose: Changes in skin are a cardinal feature of systemic sclerosis (SSc). However, there are no SSc specific patient reported outcome measures validated for use…
  • Abstract Number: 2609 • 2013 ACR/ARHP Annual Meeting

    Dutch Translation and Validation Of The University of California, Los Angeles scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument 2.0

    Jessica Meijs1, Daisy Pors1, Theodora P.M. Vliet Vlieland2, Tom W.J. Huizinga1 and Annemie J.M. Schuerwegh1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Gastrointestinal tract (GIT) involvement occurs in approximately 90% of the patients with systemic sclerosis (SSc) and leads to a decrease in health-related quality of…
  • Abstract Number: 1563 • 2012 ACR/ARHP Annual Meeting

    Is Automated DATA Capture As Reliable As Manual DATA Entry in Survey Based Research?

    Rachel A. Mikolaitis1, Jessica Cornejo2, Chris Alonzo1, Joel A. Block1 and Meenakshi Jolly2, 1Section of Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: The collection of patient reported outcomes requires accruing survey data from patients during routine medical visits. Many of these are paper-based and require manual…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology